Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy

N/ATerminatedNCT00542594

AstraZeneca1,840 enrolled

Overview

The purpose of this survey is to describe long-term tolerance as seen under current conditions of use for anastrozole.

Study Type

OBSERVATIONAL

Enrollment

1,840

Conditions

Breast Cancer

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * woman treated with anastrozole as adjuvant therapy for hormone-dependant breast cancer in post-menopausal women with positive hormone-receptors

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.